Xenon Pharmaceuticals (XENE) Total Debt (2017 - 2020)
Xenon Pharmaceuticals (XENE) posted quarterly Total Debt of $15.7 million for Q1 2020, up 3.55% year-over-year from $15.1 million in Q2 2019, and up 0.88% quarter-over-quarter from $15.5 million in Q4 2019.
Xenon Pharmaceuticals (XENE) Total Debt (2017 - 2020) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Total Debt for 4 consecutive years, with $15.7 million the latest figure, recorded in Q1 2020.
- In Q1 2020, Total Debt rose 3.55% year-over-year to $15.7 million; the TTM figure through Mar 2020 stood at $15.7 million (up 3.55% YoY), while the FY2019 annual figure was $15.5 million, up 3.5% from the prior year.
- Total Debt climbed to $15.7 million in Q1 2020 per XENE's latest filing, from $15.5 million in the prior quarter.
- Across five years, Total Debt topped out at $15.7 million in Q1 2020 and bottomed at $6.8 million in Q4 2017.
- Historically, Total Debt has averaged $13.2 million across 4 years, with a median of $15.1 million in 2018.
- Annual changes were most pronounced in 2018 — Total Debt surged 120.66% — and 2019, when it increased 3.47%.
- Xenon Pharmaceuticals' Total Debt stood at $6.8 million in 2017, then soared by 120.66% to $15.0 million in 2018, then advanced by 3.5% to $15.5 million in 2019, then rose by 0.88% to $15.7 million in 2020.
- Business Quant data shows XENE's Total Debt at $15.7 million in Q1 2020, $15.5 million in Q4 2019, and $15.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 15.68 Mn |
| Dec 31, 2019 | 15.54 Mn |
| Sep 30, 2019 | 15.40 Mn |
| Jun 30, 2019 | 15.27 Mn |
| Mar 31, 2019 | 15.14 Mn |
| Dec 31, 2018 | 15.01 Mn |
| Sep 30, 2018 | 14.89 Mn |
| Jun 30, 2018 | 11.72 Mn |
| Mar 31, 2018 | 6.88 Mn |
| Dec 31, 2017 | 6.80 Mn |